/
Login
Analysis Scores
Lothien Robustness Score?
39/100
Weak
The factor score and time-horizon weights were measured only on the past data of companies that trade today; companies that left the exchange in the past are not part of this measurement.
Neden bu skor?
Damodaran ?
27/100
Dalio Risk ?
98/100
Piotroski ?
3/9
Weak
Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4); Previous year data missing → margin comparison unavailable (C8)
Graham ?
HK$62.1
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
82/100
Lothien Sağlamlık: Çok Güçlü (82/100)
Temel göstergelerin büyük çoğunluğu pozitif. Kârlılık, büyüme ve değerleme açısından güçlü görünüm. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 10 | Negatif: 4 | Nötr: 0
Net Kâr Pozitif
Son çeyrekte HK$130M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+25.7 arttı (HK$103M → HK$130M). Kısa vadede olumlu momentum.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+67.8 arttı. Büyüme trendi sağlıklı.
3 Çeyrek Üst Üste Artış
Son 3 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+24.1 arttı (HK$293M → HK$364M). Talep güçlü.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+52.4 arttı. Şirket büyüyor.
Yüksek Net Kâr Marjı
Net kâr marjı %35.7. Her 100HK$ satıştan 36HK$ kâr kalıyor.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından HK$658M fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 33.92x — kısa vadeli borçları rahat karşılıyor.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (HK$130M) ama FCF negatif (-HK$270M). Yatırım harcamaları yüksek veya alacak birikimi var.
FAVÖK Büyümesi
FAVÖK çeyreklik %+88.7 arttı (HK$88M → HK$166M). Operasyonel verimlilik artıyor.
Yüksek F/K Uyarısı
Trailing F/K: 32.8. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek EV/EBITDA
EV/EBITDA: 32.5. Pahalı değerleme.
Düşük ROE
ROE: %4.8. Sermaye getirisi yetersiz — enflasyonun altında.
Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed
Score record
Method
How the scores are computed
· Scorecard
Data date
2026-10-23
Update frequency
Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run
Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.
AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.
Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.
WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.
Model output; not investment advice; different models can disagree. Report an error
Risk Analysis (VaR)
Çok Yüksek
252 days
Annual Volatility ?
%60.8
VaR 95% ?
%6.39
daily max loss
VaR 99% ?
%9.00
daily max loss
CVaR 95% ?
%7.54
expected loss (tail)
Max Drawdown ?
%46.4
15.10.2025 → 31.03.2026
Skewness ?
0.25
Parametrik%6.39
Historik%5.63
Cornish-Fisher%6.08
Return Distribution
Valuation
Potential?
-36.1%
ROIC ?
5.1%
DCF Value ?
83.24
Debt Cycle?
Early Expansion
Balance Sheet Analysis?
Q2026/6
Net kâr çeyreklik %+25.7 artarak 129.9M HKD oldu
Yıllık net kâr büyümesi %+67.8
Hasılat çeyreklik %+24.1 büyüdü (363.7M HKD)
Yıllık hasılat büyümesi güçlü (%+52.4)
Brüt kâr marjı güçlü: %52.2
Net kâr marjı yüksek: %35.7
FAVÖK çeyreklik %+88.7 büyüdü (165.8M HKD)
FAVÖK marjı güçlü: %45.6
Toplam borç %+11.8 arttı → 16.0M HKD
Net nakit pozisyonunda: -657.7M HKD (borçsuz)
Borç/Özkaynak oranı düşük: 0.00x
Cari oran güçlü: 33.92x — yükümlülükler rahat karşılanıyor
Nakit %-15.0 azaldı → 673.7M HKD
İşletme nakit akışı pozitif: 150.2M HKD
Serbest nakit akışı negatif: -270.2M HKD — yatırımlar nakdi aşıyor
ROE düşük: %2.1
ROA: %2.1
Toplam varlıklar: 6.3B HKD (%+0.9)
Özkaynak: 6.1B HKD (%+0.6)
İşletme kârı pozitif: 128.0M HKD
İşletme kârı büyüme: %+45.7
Ödenmiş sermaye: 115.1M HKD
Net işletme sermayesi pozitif: 4.8B HKD
Yoğun yatırım dönemi: CAPEX/Hasılat %71.8 (261.0M HKD)
Son 5 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-13.3 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 128.87 HKD
Likit varlık ağırlığı yüksek: Dönen varlıklar toplam varlıkların %78'i
Fundamental & Technical Analysis
Profitability
Net Profit Margin
%35.7
Net profit margin %35.7 — very strong. Compared to previous quarter +0.5 point increase.
ROE - Return on Equity (TTM)
%4.8
ROE %4.8 — low return on equity.
EBITDA Margin
%45.6
EBITDA margin %45.6 — operationally very efficient.
Gross Profit Margin
%52.2
Gross profit per revenue %52.2. Strong pricing power.
Free Cash Flow Margin (TTM)
%-30.3
TTM Free Cash Flow is %-30.3'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio
32.8x
Sector: 12.3x
F/K 32.8x — sector median's (12.3x) %167 above. Expensive zone.
P/B Ratio
2.10x
Sector: 1.54x
PD/DD 2.10x — sector median's (1.54x) %36 above.
EV/EBITDA
32.5x
Sector: 7.6x
EV/EBITDA 32.5x — sector median's (7.6x) %327 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio
33.92x
Current ratio 33.92x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
0.0x
Net Debt/EBITDA 0.0x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.00x
Low leverage — majority of assets financed by equity.
Growth
Revenue Growth (YoY)
%+52.4
Revenue YoY %52.4 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY)
%+67.8
Net profit YoY %67.8 increased (2026/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
39/100
Weak robustness (39/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-36.1%
Minus %36.1 expected value (71.33) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 44.66 | P/B target: 83.39 | EV/EBITDA target: 27.93 | DCF target: 83.24
Damodaran Valuation
27/100
Low Damodaran score (27/100). ROIC (%5.1) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
98/100
Low debt risk (98/100). Debt/EBITDA 0.0x — in healthy range.
Leverage: 100/100 | Debt Service: 100/100 | Quality: 89/100
ROIC - Return on Capital
%5.1
ROIC (%5.1) cost of capital (11.7%) below → destroying value.
WACC: %11.7
DCF Discounted Cash Flow
83.24
DCF (83.24) current price %25.5 below — cash flows do not support current price.
Current price: 111.70
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
3/9
Weak Piotroski (3/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4)
Weak
Graham Intrinsic Value
HK$62.1
Expensive
⚖️ Sector Comparison
P/E Ratio
32.8x
vs 12.3x
Sector median's %167 above — expensive
P/B Ratio
2.10x
vs 1.54x
Compared to sector %36 more expensive (by book value)
EV/EBITDA
32.5x
vs 7.6x
Compared to sector %327 higher EV/EBITDA
ROIC vs WACC
%5.1
vs %11.7 WACC
ROIC 6.6 bps below cost of capital
Net Profit Margin (TTM)
%32.3
vs %32.7 EBITDA margin
TTM net profit margin %32.3
TRAMA-99 Trend — Downtrend
Price (111.70), TRAMA-99 line's %13.3 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 111.70
TRAMA: 128.87
Difference: %-13.3
Charts
Indicators
BB deviation
?
RSI thresholds
?
1304 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.